Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $81.16 USD
Change Today -0.92 / -1.12%
Volume 1.9M
ESRX On Other Exchanges
ESRX is not on other exchanges.
As of 1:11 PM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

One Express Way

St. Louis, MO 63121

United States

Phone: 314-996-0900


cialty Pharmacy Services Specialty medications are used primarily for the treatment of complex diseases. These medications are characterized to include those with frequent dosing adjustments, intensive clinical monitoring, the need for patient training, specialized product administration requirements, and/or those limited to specialty pharmacy networks by manufacturers. Through a combination of assets and capabilities, the company provides an improved level of care and therapy management for patients taking specialty medications, increased visibility, and improved outcomes for payors, as well as custom programs for biopharmaceutical manufacturers. The company’s subsidiaries, such as Accredo Health Group, Inc. and CuraScript Specialty Pharmacy (which is in the process of being rebranded), collectively referred to as ‘Accredo’, are focused on dispensing injectable, infused, oral or inhaled drugs that require a level of clinical services and support compared to what is available from traditional pharmacies. Accredo is able to achieve healthier outcomes and reduced waste through a disease-centric organization, specialty trained clinicians, a nationwide footprint, a network of employed and contracted in-home nursing services, reimbursement and patient assistance programs, and bio-pharma services. The company’s subsidiary, Freedom Fertility (FreedomFP), is a specialty pharmacy focused on the needs of fertility patients and providers. Through FreedomFP, the company provides insurance assistance and patient education and support. Specialty Benefit Management is the company’s next-generation approach to managing total specialty drug spend and improving patient care. The company provides its clients a toolset designed to manage total specialty spend regardless of which benefit the drug is processed through. The company’s capabilities include guaranteeing savings through medical benefit management services, ensuring the safe and appropriate use of specialty drugs, redirecting patients and medications to the lowest-cost and appropriate channel, verifying claims are paid at the contracted rate, improving opportunities to achieve rebates, and where clinically appropriate, moving drug coverage from medical to pharmacy benefit and to lower-cost sites of care. Retail Network Pharmacy Administration The company contracts with retail pharmacies to provide prescription drugs to members of the pharmacy benefit plans that the company manages. It also manages networks of pharmacies customized for or under direct contract with specific clients. In addition, it has contracted pharmacy provider networks to comply with CMS (the Centers for Medicare & Medicaid Services) access requirements for the Medicare Part D Prescription Drug Program (Medicare Part D). Benefit Design Consultation The company consults with its clients on how best to structure and leverage the pharmacy benefit to meet their objectives for benefits, providing access to needed care while eliminating waste. It supports its clients in determining the scope and conditions of coverage and offering incentives for members and their providers. The company adopts programs that drive use of prescription drugs. Drug Utilization Review The company’s electronic claims processing system enables it to implement intervention programs to manage prescription drug utilization. The system could alert the pharmacist to drug safety concerns, generic substitution, and therapeutic intervention opportunities, as well as formulary adherence issues; and could also administer prior authorization, step therapy protocol programs, and drug quantity management at the time a claim is submitted for processing. The company’s claims processing system also generates a database of drug utilization information that could be accessed at the time a prescription is dispensed, on a retrospective basis to analyze utilization trends and prescribing patterns for intensive management of the drug benefit, and on a prospective basis to help support pharmacists in drug therapy management decisions. Drug Formulary Management The company’s formulary management services support clients in choos


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ESRX:US $81.22 USD -0.87

ESRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $108.41 USD -4.63
Anthem Inc $139.34 USD -3.51
Cardinal Health Inc $77.98 USD -1.57
Kroger Co/The $37.13 USD -0.94
Walgreens Boots Alliance Inc $84.43 USD -3.53
View Industry Companies

Industry Analysis


Industry Average

Valuation ESRX Industry Range
Price/Earnings 27.0x
Price/Sales 0.5x
Price/Book 3.5x
Price/Cash Flow 25.2x
TEV/Sales 0.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXPRESS SCRIPTS HOLDING CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at